We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Chemists Synthesize a Common Antibiotic

By Biotechdaily staff writers
Posted on 31 Mar 2006
Researchers have synthesized the antibiotic nisin and have determined its crystal structure and the mechanism that controls its antibacterial enzyme activity.

Nisin is an inhibitory polycyclic peptide with 34 amino acid residues and is used as a food preservative. More...
It contains the uncommon amino acids lanthionine, methyllanthionine, dehydroalanine, and dehydro-amino-butyric acid. These special amino acids are synthesized by posttranslational modifications. In these reactions, a ribosomally synthesized 57 amino acid peptide is converted to the final peptide. The unsaturated amino acids originate from serine and threonine.

Nisin is produced by fermentation using the bacterium Lactococcus lactis. Commercially it is obtained from natural substrates including milk and is not chemically synthesized. It is used in processed cheese production to extend shelf life by suppressing Gram-positive spoilage and pathogenic bacteria. Due to its highly selective spectrum of activity it is also employed as an agent in microbiologic media for the isolation of gram-negative bacteria, yeast, and molds.

Investigators at the University of Illinois (Urbana-Champaign, USA) used a single cyclase enzyme to re-create the synthetic process that normally occurs in L lactis. Results published in the March 10, 2006, issue of Science revealed that the NisC (nisin cyclase) enzyme catalyzes the formation of ten new chemical bonds in a stereochemically defined fashion, resulting in the five characteristic thioether rings required for nisin's biologic activity.

"Despite all the progress in synthetic chemistry, we cannot come close to making a compound like nisin efficiently,” said contributing author Dr. Wilfred A. van der Donk, professor of chemistry at the University of Illinois. "Synthetic chemists in the past needed 67 steps to make it, while nature uses just two enzymes. One of these is the cyclase whose activity we have demonstrated in this paper.”



Related Links:
University of Illinois

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The POC diagnostic test aims to use fingerstick blood, serum, or plasma sample to detect typhoid fever (Photo courtesy of Adobe Stock)

POC Test Uses Fingerstick Blood, Serum, Or Plasma Sample to Detect Typhoid Fever

Typhoid fever is an acute febrile illness caused by Salmonella enterica serovar Typhi (S. Typhi) and affects an estimated 11–21 million people globally each year, resulting in approximately 128,000–161,000... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.